Experimentally, it has been studied as an inhibitor of phospholipase A2 , an enzyme involved in inflammatory processes.
The drug was removed from the U.S. market in 1990 but remains available as a Research-Only Compound for laboratory studies. Pharmacological Mechanism butacaine sulfate
It can modulate the activity of phospholipids (like cardiolipin) and stimulate the rate of cation translocation in certain experimental models. Chemical & Physical Properties Chemical Class: Ester of -aminobenzoic acid. Experimentally, it has been studied as an inhibitor